Speculation grows as state and federal investigations probe price of insulin increase Rising insulin costs have spurred state and federal prosecutors to demand information from insulin manufacturers and several pharmacy benefit managers (PBMs). The investigation appears to be focused on whether the drug companies and pharmacy industry middlemen have conspired to let the price of…